Free Access
Issue
Vet. Res.
Volume 31, Number 5, September-October 2000
Page(s) 507 - 515
DOI https://doi.org/10.1051/vetres:2000136
How to cite this article Vet. Res. (2000) 507-515

References

1
Billinghurst R.C., Fretz P.B., Gordon J.R., Induction of intra-articular tumor necrosis factor during acute inflammatory responses in equine arthritis, Equine Vet. J. 27 (1995) 208-216.
2
Bradford M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
3
Brama P.A., Tekoppele J.M., Beeckman B., van Weeren P.R., Barneveld A., Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis, and osteochondrosis, Ann. Rheum. Dis. 57 (1998) 697-699.
4
Birkedal-Hansen H., Moore W.G.I., Bodden M.K., Windsor L.J., Birkedal-Hansen B., Decarlo A., Engler J.A., Matrix metalloproteinases: a review, Crit. Rev. Oral Biol. Med. 4 (1993) 197-250.
5
Cao J., Sato H., Takino T., Seiki M., The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation, J. Biol. Chem. 270 (1995) 801-805.
6
Cawston T.E., Proteinases and inhibitors, Br. Med. Bull. 51 (1995) 385-401.
7
Clegg P.D., Carter S.D., Matrix metalloproteinase-2 and -9 are activated in joint diseases, Equine Vet. J. 31 (1999) 324-330.
8
Clegg P.D., Burke R.M., Coughlan A.R., Riggs C.M., Carter S.D., Characterisation of equine matrix metalloproteinase 2 and 9, and identification of the cellular sources of these enzymes in joints, Equine Vet. J. 29 (1997) 335-342.
9
Clegg P.D., Coughlan A.R., Riggs C.M., Carter S.D., Matrix metalloproteinases 2 and 9 in equine synovial fluids, Equine Vet. J. 29 (1997) 343-348.
10
Clegg P.D., Coughlan A.R., Carter S.D., Equine TIMP-1 and TIMP-2: Identification, activity and cellular sources, Equine Vet. J. 30 (1998) 416-423.
11
Gaudin P., Razakaboay M., Surla A., Berthier S., Fauconnier J., Morel F., Phelip X., A study of metalloproteinases in fifty joint fluid specimens, Rev. Rhum. Engl. Ed. 64 (1997) 375-381.
12
Itoh Y., Binner S., Nagase H., Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and TIMP2 by 4-APMA, Biochem. J. 308 (1995) 645-651.
13
Ishiguro N., Ito T., Miyazaki K., Iwata H., Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and glycosaminoglycans in synovial fluid from patients with rheumatoid arthritis, J. Rheumatol. 26 (1999) 34-40.
14
Johnson P.J., Tyagi S.C., Katwa L.C., Ganjam V.K., Moore L.A., Kreeger J.M., Messer N.T., Activation of extracellular matrix metalloproteinases in equine laminitis, Vet. Rec. 142 (1998) 392-396.
15
Mackay R.J., Merritt A.M., Zertuche J.M., Whittington M., Skelley L.A., Tumor necrosis factor activity in the circulation of horses given endotoxin, Am. J. Vet. Res. 52 (1991) 533-538.
16
McIlwraith C.W., General pathobiology of the joint and response to injury, in Joint Disease in the Horse, Saunders Ed. (1996) 40-70.
17
Spiers S., May S.A., Bennett D., Edwards G.B., Cellular sources of proteolytic enzymes in equine joints, Equine Vet. J. 26 (1994) 43-47.
18
Todhunter P.G., Kincaid S.A., Todhunter R.J., Kammermann J.R., Johnstone B., Baird A.N., Hanson R.R., Wright J.M., Lin H.C., Purohit R.C., Immunohistochemical analysis of an equine model of synovitis-induced arthritis, Am. J. Vet. Res. 57 (1996) 1080-1093.
19
Woessner J.F., Matrix metalloproteinases and their inhibitors in connective tissue remodeling, Fed. Amer. Soc. Exp. Biol. J. 5 (1991) 2145-2154.


Abstract

Copyright INRA, EDP Sciences

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.